
Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.
我们正在追踪 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的市场扩张
Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development)你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
没有近期新闻
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的业务、市场和增长信号的快速解答。
